151 related articles for article (PubMed ID: 12663990)
1. Antisense basic fibroblast growth factor alters the time course of mitogen-activated protein kinase in arterialized vein graft remodeling.
Yamashita A; Hanna AK; Hirata S; Dardik A; Sumpio BE
J Vasc Surg; 2003 Apr; 37(4):866-73. PubMed ID: 12663990
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral-mediated expression of antisense RNA to basic fibroblast growth factor reduces tangential stress in arterialized vein grafts.
Hanna AK; Durán WN; Leconte I; Fox JC; Neschis DG; Hobson RW; Golden MA
J Vasc Surg; 2000 Apr; 31(4):770-80. PubMed ID: 10753285
[TBL] [Abstract][Full Text] [Related]
3. Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model.
Neschis DG; Safford SD; Hanna AK; Fox JC; Golden MA
J Vasc Surg; 1998 Jan; 27(1):126-34. PubMed ID: 9474090
[TBL] [Abstract][Full Text] [Related]
4. Vein graft arterialization causes differential activation of mitogen-activated protein kinases.
Saunders PC; Pintucci G; Bizekis CS; Sharony R; Hyman KM; Saponara F; Baumann FG; Grossi EA; Colvin SB; Mignatti P; Galloway AC
J Thorac Cardiovasc Surg; 2004 May; 127(5):1276-84. PubMed ID: 15115983
[TBL] [Abstract][Full Text] [Related]
5. p38 MAPK inhibitor, CBS3830 limits vascular remodelling in arterialised vein grafts.
Ge JJ; Zhao ZW; Zhou ZC; Wu S; Zhang R; Pan FM; Abendroth DK
Heart Lung Circ; 2013 Sep; 22(9):751-8. PubMed ID: 23523564
[TBL] [Abstract][Full Text] [Related]
6. Mechanical endothelial damage results in basic fibroblast growth factor-mediated activation of extracellular signal-regulated kinases.
Pintucci G; Steinberg BM; Seghezzi G; Yun J; Apazidis A; Baumann FG; Grossi EA; Colvin SB; Mignatti P; Galloway AC
Surgery; 1999 Aug; 126(2):422-7. PubMed ID: 10455916
[TBL] [Abstract][Full Text] [Related]
7. Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury.
Hanna AK; Fox JC; Neschis DG; Safford SD; Swain JL; Golden MA
J Vasc Surg; 1997 Feb; 25(2):320-5. PubMed ID: 9052566
[TBL] [Abstract][Full Text] [Related]
8. Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1.
Wolff RA; Ryomoto M; Stark VE; Malinowski R; Tomas JJ; Stinauer MA; Hullett DA; Hoch JR
J Vasc Surg; 2005 Mar; 41(3):498-508. PubMed ID: 15838486
[TBL] [Abstract][Full Text] [Related]
9. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
Gulkarov I; Bohmann K; Cinnante KM; Pirelli L; Yu PJ; Grau JB; Pintucci G; Galloway AC; Mignatti P
J Surg Res; 2009 Jun; 154(1):150-6. PubMed ID: 18805551
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-Activated Protein Kinases Mediate Adventitial Fibroblast Activation and Neointima Formation via GATA4/Cyclin D1 Axis.
Chen J; Wei JQ; Hong MN; Zhang Z; Zhou HD; Lu YY; Zhang J; Guo YT; Chen X; Wang JG; Gao PJ; Li XD
Cardiovasc Drugs Ther; 2024 Jun; 38(3):527-538. PubMed ID: 36652042
[TBL] [Abstract][Full Text] [Related]
11. Modulation of vascular remodeling induced by a brief intraluminal exposure to the recombinant R7020 strain of Herpes simplex-1.
Baldwin ZK; Chandiwal A; Balasubramanian V; Pearce BJ; Curi MA; Skelly CL; Huang WW; Vosicky JE; Roizman B; Weichselbaum RR; Schwartz LB
J Vasc Surg; 2005 Jan; 41(1):115-21. PubMed ID: 15696053
[TBL] [Abstract][Full Text] [Related]
12. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.
Wu B; Werlin EC; Chen M; Mottola G; Chatterjee A; Lance KD; Bernards DA; Sansbury BE; Spite M; Desai TA; Conte MS
J Vasc Surg; 2018 Dec; 68(6S):188S-200S.e4. PubMed ID: 30064835
[TBL] [Abstract][Full Text] [Related]
13. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
[TBL] [Abstract][Full Text] [Related]
14. Activation of mitogen-activated protein kinases during preparation of vein grafts and modulation by a synthetic inhibitor.
Bizekis C; Pintucci G; Derivaux CC; Saponara F; Kim JH; Hyman KM; Sharony R; Grossi EA; Baumann FG; Mignatti P; Galloway AC
J Thorac Cardiovasc Surg; 2003 Sep; 126(3):659-65. PubMed ID: 14502136
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin.
Hu Y; Zou Y; Dietrich H; Wick G; Xu Q
Circulation; 1999 Aug; 100(8):861-8. PubMed ID: 10458724
[TBL] [Abstract][Full Text] [Related]
16. Alterations in wall tension and shear stress modulate tyrosine kinase signaling and wall remodeling in experimental vein grafts.
Huynh TT; Davies MG; Trovato MJ; Svendsen E; Hagen PO
J Vasc Surg; 1999 Feb; 29(2):334-44. PubMed ID: 9950991
[TBL] [Abstract][Full Text] [Related]
17. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor.
Luo Z; Asahara T; Tsurumi Y; Isner JM; Symes JF
J Vasc Surg; 1998 Jan; 27(1):167-73. PubMed ID: 9474095
[TBL] [Abstract][Full Text] [Related]
18. Influence of ischemic injury on vein graft remodeling: role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation.
Sakaguchi T; Asai T; Belov D; Okada M; Pinsky DJ; Schmidt AM; Naka Y
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):129-37. PubMed ID: 15632834
[TBL] [Abstract][Full Text] [Related]
19. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
20. Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases.
Mayr M; Li C; Zou Y; Huemer U; Hu Y; Xu Q
FASEB J; 2000 Feb; 14(2):261-70. PubMed ID: 10660448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
